Veloxis Pharmaceuticals A/S operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Veloxis Pharmaceuticals A/S with three other
miscellaneous service companies in Europe:
sales of 8.87 million Euro [US$10.46 million]
(74.92 million Swedish Kronor [US$9.24 million]
Evolva Holding SA
based in Switzerland
(9.58 million Swiss Francs [US$9.81 million]
of which 100%
was Novel Food Nutritional & Pharmaceutical).